Pitz, Vanessa http://orcid.org/0000-0002-2964-5553
Makarious, Mary B. http://orcid.org/0000-0002-7978-1051
Bandres-Ciga, Sara
Iwaki, Hirotaka
Aslibekyan, Stella
Auton, Adam
Babalola, Elizabeth
Bell, Robert K.
Bielenberg, Jessica
Bryc, Katarzyna
Bullis, Emily
Coker, Daniella
Partida, Gabriel Cuellar
Dhamija, Devika
Das, Sayantan
Elson, Sarah L.
Eriksson, Nicholas
Filshtein, Teresa
Fitch, Alison
Fletez-Brant, Kipper
Fontanillas, Pierre
Freyman, Will
Granka, Julie M.
Hernandez, Alejandro
Hicks, Barry
Hinds, David A.
Jewett, Ethan M.
Jiang, Yunxuan
Kukar, Katelyn
Kwong, Alan
Lin, Keng-Han
Llamas, Bianca A.
Lowe, Maya
McCreight, Jey C.
McIntyre, Matthew H.
Micheletti, Steven J.
Moreno, Meghan E.
Nandakumar, Priyanka
Nguyen, Dominique T.
Noblin, Elizabeth S.
O’Connell, Jared
Petrakovitz, Aaron A.
Poznik, G. David
Reynoso, Alexandra
Schumacher, Morgan
Shastri, Anjali J.
Shelton, Janie F.
Shi, Jingchunzi
Shringarpure, Suyash
Su, Qiaojuan Jane
Tat, Susana A.
Tchakouté, Christophe Toukam
Tran, Vinh
Tung, Joyce Y.
Wang, Xin
Wang, Wei
Weldon, Catherine H.
Wilton, Peter
Wong, Corinna D.
Singleton, Andrew B. http://orcid.org/0000-0001-5606-700X
Nalls, Mike http://orcid.org/0000-0003-0319-4325
Heilbron, Karl
Blauwendraat, Cornelis http://orcid.org/0000-0001-9358-8111
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Article History
Received: 27 March 2023
Accepted: 24 November 2023
First Online: 8 January 2024
Competing interests
: The authors declare the following competing non-financial interests: Author A.B.S. is associate editor of npj Parkinson’s Disease. A.B.S. was not involved in the journal’s review, or decisions related to this manuscript. Competing Financial Interests are disclosed: M.A.N. is a consultant employed by Data Tecnica International, whose participation in this is part of a consulting agreement between the US National Institutes of Health and said company. M.A.N. also serves on the scientific advisory board for Clover Therapeutics and is an advisor to Neuron23 Inc. K.H. and members of the 23andMe Research Team are employees of 23andMe, Inc. and hold stock or stock options in 23andMe. All other authors have no competing interests.